Determinants of in vitro drug susceptibility testing of Plasmodium vivax

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 1040-1045

  Russell, B ^a   Chalfein, F ^b   Prasetyorini, B ^c   Kenangalem, E ^b,d   Piera, K ^a   Suwanarusk, R ^a   Brockman, A ^a   Prayoga, P ^b   Sugiarto, P ^e   Cheng, Q ^f   Tjitra, E ^c   Anstey, N M ^a   Price, R N ^a,g  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^d District Ministry of Health   (Indonesia)

^e Mitra Masyarakat Hospital Indonesia   (Indonesia)

^f AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; MEFLOQUINE; PIPERAQUINE;

ARTICLE; CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG SENSITIVITY; IC 50; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; SCHIZONT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; HUMANS; INHIBITORY CONCENTRATION 50; LIFE CYCLE STAGES; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SCHIZONTS; TIME FACTORS;

EID: 40549118492     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01334-07     Document Type: Article

References (25)

1. Baird, J. K., H. Basri, Purnomo, M. J. Bangs, B. Subianto, L. C. Patchen, and S. L. Hoffman. 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. I. Trop. Med. Hyg. 44:547-552.
2. Baird, J. K., B. Leksana, S. Masbar, D. J. Fryauff, M. A. Sutanihardja, Suradi, F. S. Wignall, and S. L. Hoffman. 1997. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am. J. Trop. Med. Hyg. 56:621-026.
3. Chen, N., A. Auliff, K. Rieckmann, M. Gatton, and Q. Cheng. 2007. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 195:934-941.
4. Chotivanich, K., R. Udomsangpetch, W. Chierakul, P. N. Newton, R. Ruangveerayuth, S. Pukrittayakamee, S. Looareesuwan, and N. J. White. 2004. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am. J. Trop. Med. Hyg. 70:395-397.
5. Druilhe, P., P. Brasseur, C. Blanc, and M. Makler. 2007. Improved assessment of Plasmodium vivax response to antimalarial drugs by a colorimetric double-site Plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay. Antimicrob. Agents Chemother. 51:2112-2116.
6. Fryauff, D. J., S. Tuti, A. Mardi, S. Masbar, R. Patipelohi, B. Leksana, K. C. Kain, M. J. Bangs, T. L. Richie, and J. K. Baird. 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg. 59:513-518.
7. Gajanana, A., and A. N. Raichowdhuri. 1984. Plasmodium vivax: micro in vitro test for assaying chloroquine susceptibility. Trans. R. Soc. Trop. Med. Hyg. 78:416-417.
8. Galinski, M. R., C. C. Medina, P. Ingravallo, and J. W. Barnwell. 1992. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 69:1213-1226.
9. Hamedi, Y., M. Nateghpour, B. Soonthornsata, P. Tan-ariya, S. Kojima, D. Chindanond, and S. Looareesuwan. 2003. Monitoring of Plasmodium vivax sensitivity to chloroquine in vitro in Thailand. Trans. R. Soc. Trop. Med. Hyg. 97:435-437.
10. Imwong, M., G. Snounou, S. Pukrittayakamee, N. Tanomsing, J. R. Kim, A. Nandy, J. P. Guthmann, F. Nosten, J. Carlton, S. Looareesuwan, S. Nair, D. Sudimack, N. P. Day, T. J. Anderson, and N. J. White. 2007. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195:927-933.
11. Kosaisavee, V., R. Suwanarusk, F. Nosten, D. E. Kyle, M. Barrends, J. Jones, R. Price, B. Russell, and U. Lek-Uthai. 2006. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates. Exp. Parasitol. 114:34-39.
12. Lux, D., S. Prajakwong, H. Kollaritsch, G. Wernsdorfer, and W. H. Wernsdorfer. 2003. In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand. Wien. Klin. Wochenschr. 115(Suppl. 3):50-54.
13. Powell, R. D., and E. M. Berglund. 1974. Effects of chloroquine upon the maturation of asexual erythrocytic forms of Plasmodium vivax in vitro. Am. J. Trop. Med. Hyg. 23:1007-1014.
14. Pukrittayakamee, S., A. Chantra, J. A. Simpson, S. Vanijanonta, R. Clemens, S. Looareesuwan, and N. J. White. 2000. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob. Agents Chemother. 44:1680-1685.
15. Ratcliff, A., H. Siswantoro, E. Kenangalem, R. Maristela, R. M. Wuwung, F. Laihad, E. P. Ebsworth, N. M. Anstey, E. Tjitra, and R. N. Price. 2007. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 369:757-765.
16. Ratcliff, A., H. Siswantoro, E. Kenangalem, M. Wuwung, A. Brockman, M. D. Edstein, F. Laihad, E. P. Ebsworth, N. M. Anstey, E. Tjitra, and R. N. Price. 2007. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 101:351-359.
17. Reilly, H. B., H. Wang, J. A. Steuter, A. M. Marx, and M. T. Ferdig. 2007. Quantitative dissection of clone-specific growth rates in cultured malaria parasites. Int. J. Parasitol. 37:1599-1607.
18. Rieckmann, K. H., D. R. Davis, and D. C. Hutton. 1989. Plasmodium vivax resistance to chloroquine? Lancet ii: 1183-1184.
19. Russell, B. M., R. Udomsangpetch, K. H. Rieckmann, B. M. Kotecka, R. E. Coleman, and J. Sattabongkot. 2003. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob. Agents Chemother. 47:170-173.
20. Soto, J., J. Toledo, P. Gutierrez, M. Luzz, N. Llinas, N. Cedeno, M. Dunne, and J. Berman. 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am. J. Trop. Med. Hyg. 65:90-93.
21. Sumawinata, I. W., Bernadeta, B. Leksana, A. Sutamihardja, Purnomo, B. Subianto, Sekartuti, D. J. Fryauff, and J. K. Baird. 2003. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am. J. Trop. Med. Hyg. 68:416-420.
22. Suwanarusk, R., B. Russell, M. Chavchich, F. Chalfein, E. Kenangalem, V. Kosaisavee, B. Prasetyorini, K. A. Piera, M. Barends, A. Brockman, U. Lek-Uthai, N. M. Anstey, E. Tjitra, F. Nosten, Q. Cheng, and R. N. Price. 2007. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS ONE 2:e1089.
23. Tasanor, O., H. Noedl, K. Na-Bangchang, K. Congpuong, J. Sirichaisinthop, and W. H. Wernsdorfer. 2002. An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine. Acta Trop. 83:49-61.
24. Tasanor, O., R. Ruengweerayut, J. Sirichaisinthop, K. Congpuong, W. H. Wernsdorfer, and K. Na-Bangchang. 2006. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 100:410-418.
25. Yayon, A., J. A. Vande Waa, M. Yayon, T. G. Geary, and J. B. Jensen. 1983. Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J. Protozool. 30:642-647.